ACIST Medical Systems Announces Approval and Launch of Next-Generation FFR System

ACIST Medical Systems Inc., a Bracco Group Company, has globally launched its ACIST RXi Mini System, the next-generation version of its RXi Rapid Exchange FFR System.

The RXi Mini is designed to provide fractional flow reserve (FFR) measurements to complement angiography, provide qualitative assessment of lesion severity, and inform intervention strategy in both diagnosis and treatment of coronary and peripheral artery disease. The system is designed to seamlessly integrate with existing hemodynamic systems and FFR software. The RXi Mini offers flexible mounting configurations, a simple and intuitive user interface, and a small and unobtrusive system profile that adapts to existing workflow and maximizes procedural efficiency.
 
The first case in the United States and the world was performed by Dr. Michael Lim, M.D., director of Cardiology at St. Louis University in St. Louis, Mo. During a complex case, Lim used the RXi Mini System to measure FFR multiple times during the procedure. The small RXi Mini system is about the size of a fist and connects into hospital hemodynamic systems where the measurements can be taken and recorded by lab staff, making the procedure go more smoothly and quickly.

“ACIST has raised the bar in making physiology accessible and easy to use in the cath lab setting,” Lim noted. “FFR is the gold standard in diagnosing which lesions will most likely benefit from coronary interventions, including stent placement. The ACIST Rapid FFR Mini RXi system makes it much simpler to perform FFR, whenever it is called for. With this advance, it continues to become easier to guide treatment decisions by invasive physiologic measurement—there really aren’t that many excuses left for the interventionalist to skip this step.”
 
Unlike standard pressure wires, the ACIST RXi Mini System and Navvus Rapid Exchange FFR MicroCatheter, allows physicians to use their 0.014-inch guide wire of choice throughout the procedure, addressing challenges of pressure wires, including accessibility in challenging anatomies, maintaining wire position, pressure‐measurement drift and ease of obtaining post‐intervention FFR.
 
“ACIST is excited about the additional value and flexibility that the RXi Mini will provide the cath lab,” said Brad Fox, president and CEO of ACIST Medical Systems. “This next-generation FFR solution reflects our continued organizational commitment to providing technologies that simplify procedures and help physicians improve patient care.”
 
ACIST Medical Systems Inc. is an interventional and diagnostic technology company with a portfolio of products, including the world’s first Rapid Exchange FFR and High Definition IVUS systems. It is also a global developer of advanced contrast imaging systems for cardiovascular angiography and radiology imaging. As part of the Bracco Group, ACIST benefits from the resources of a multinational conglomerate with expertise in cath lab technology. Headquartered in Eden Prairie, Minn., ACIST has worldwide presence with over 300 direct employees and facilities in Silicon Valley, Calif.; Heerlen, The Netherlands; and Tokyo, Japan.
 
Bracco has headquarters in Milan, Italy, and was founded in 1927. It is active in the healthcare sector through Bracco Imaging (diagnostic imaging), ACIST Medical Systems and HLT (cardiology) and the Centro Diagnostico Italiano diagnostic clinic. It has around 3,400 employees and annual total consolidated revenues of over 1.3 billion euros. Bracco operates in more than 100 countries worldwide.